We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+0.12%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$306B
AUM Growth
+$4.93B
Cap. Flow
+$7.83B
Cap. Flow %
2.56%
Top 10 Hldgs %
17.03%
Holding
3,610
New
202
Increased
2,185
Reduced
922
Closed
109

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$269M
2
AMZN icon
Amazon
AMZN
+$242M
3
AAPL icon
Apple
AAPL
+$215M
4
AMGN icon
Amgen
AMGN
+$212M
5
CFG icon
Citizens Financial Group
CFG
+$193M

Sector Composition

Rank Sector Weight
1 Technology 20.58%
2 Financials 13.47%
3 Healthcare 12.09%
4 Consumer Discretionary 10.78%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRD.A icon
3201
Crawford & Co Class A
CRD.A
$640M
$412K ﹤0.01%
45,845
-73,098
-61% -$716K
KVHI icon
3202
KVH Industries
KVHI
$151M
$411K ﹤0.01%
42,605
+5,362
+14% +$58.2K
ONCR
3203
DELISTED
Oncorus, Inc.
ONCR
$405K ﹤0.01%
43,295
-40,198
-48% -$459K
ADN
3204
DELISTED
Advent Technologies
ADN
$404K ﹤0.01%
1,547
-5,269
-77% -$1.28M
IMUX icon
3205
Immunic
IMUX
$211M
$403K ﹤0.01%
4,544
+598
+15% +$58.9K
HBT icon
3206
HBT Financial
HBT
$1.32B
$397K ﹤0.01%
25,480
-43,499
-63% -$703K
HARP
3207
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$395K ﹤0.01%
4,988
-12,322
-71% -$1.24M
ALKT icon
3208
Alkami Technology
ALKT
$2.12B
$394K ﹤0.01%
15,936
+1,180
+8% +$35.2K
RTB
3209
RTB Digital
RTB
$232M
$393K ﹤0.01%
135
+9
+7% +$30.2K
GORV
3210
DELISTED
Lazydays
GORV
$390K ﹤0.01%
608
ACET icon
3211
Adicet Bio
ACET
$77M
$389K ﹤0.01%
3,098
ATCX
3212
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$388K ﹤0.01%
38,134
+4,950
+15% +$51.2K
CARM
3213
DELISTED
Carisma Therapeutics
CARM
$386K ﹤0.01%
24,277
+2,758
+13% +$132K
GLSI icon
3214
Greenwich LifeSciences
GLSI
$228M
$384K ﹤0.01%
9,819
TASK icon
3215
TaskUs
TASK
$633M
$383K ﹤0.01%
+5,765
New +$273K
FOA icon
3216
Finance of America Companies
FOA
$193M
$382K ﹤0.01%
7,712
-9,788
-56% -$581K
HYRE
3217
DELISTED
HyreCar Inc. Common Stock
HYRE
$376K ﹤0.01%
44,121
BMTX
3218
DELISTED
BM Technologies, Inc.
BMTX
$373K ﹤0.01%
43,364
XGN icon
3219
Exagen
XGN
$164M
$369K ﹤0.01%
27,074
OMGA
3220
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$369K ﹤0.01%
+19,572
New +$375K
RPID icon
3221
Rapid Micro Biosystems
RPID
$84.8M
$366K ﹤0.01%
+19,779
New +$409K
PAMT
3222
PAMT Corp
PAMT
$281M
$363K ﹤0.01%
16,132
-3,344
-17% -$57.5K
ASML icon
3223
ASML
ASML
$691B
$361K ﹤0.01%
484
-59
-11% -$46.4K
SLDB icon
3224
Solid Biosciences
SLDB
$949M
$361K ﹤0.01%
10,062
CYT
3225
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$361K ﹤0.01%
+20,569
New +$384K

Similar funds

Charles Schwab's Q3 2021 Portfolio in Review

As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
  • Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
  • Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
  • Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
  • Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
  • Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
  • Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.

Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.